top of page

Our

Pipeline

Indication            Target             Mode of Action   

Lead Generation

 Feasibility       

Candidate Selection

IND Enabling

Oncology

STING

Agonist

 IND enabling

Inflammation

STING

Antagonist

Lead Generation stage

Oncology

ACSS2

Inhibitor

Candidate Selection stage

Oncology

TDO/IDO

Inhibitor

IND enabling stage

Oncology

HPK1

Inhibitor

Lead Generation stage

Lead Generation stage

bottom of page